MENU
+Compare
PGNY
Stock ticker: NASDAQ
AS OF
Dec 26 closing price
Price
$25.80
Change
+$0.29 (+1.14%)
Capitalization
2.22B

PGNY Progyny Forecast, Technical & Fundamental Analysis

Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions... Show more

PGNY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for PGNY with price predictions
Dec 26, 2025

PGNY's Stochastic Oscillator stoops into oversold zone

The Stochastic Oscillator for PGNY moved into oversold territory on December 26, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for PGNY moved above the 200-day moving average on December 11, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PGNY advanced for three days, in of 326 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 188 cases where PGNY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for PGNY moved out of overbought territory on November 28, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on December 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PGNY as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for PGNY turned negative on December 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PGNY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. PGNY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.971) is normal, around the industry mean (4.098). P/E Ratio (41.613) is within average values for comparable stocks, (34.986). PGNY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.237). PGNY's Dividend Yield (0.000) is considerably lower than the industry average of (0.023). PGNY's P/S Ratio (1.852) is slightly higher than the industry average of (0.665).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PGNY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
PGNY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

PGNY is expected to report earnings to fall 68.47% to 14 cents per share on March 02

Progyny PGNY Stock Earnings Reports
Q4'25
Est.
$0.14
Q3'25
Beat
by $0.32
Q2'25
Beat
by $0.32
Q1'25
Beat
by $0.30
Q4'24
Beat
by $0.32
The last earnings report on November 06 showed earnings per share of 44 cents, beating the estimate of 12 cents. With 1.01M shares outstanding, the current market capitalization sits at 2.22B.
A.I. Advisor
published General Information

General Information

a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools

Industry ManagedHealthCare

Profile
Fundamentals
Details
Industry
N/A
Address
1359 Broadway
Phone
+1 212 888-3124
Employees
566
Web
https://www.progyny.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GERAX11.230.10
+0.90%
Goldman Sachs Em Mkts Eq Insghts A
MVCHX30.29N/A
N/A
MFS Mid Cap Value R3
KCVIX18.52N/A
N/A
Knights of Columbus Large Cap Value I
CRFIX12.36-0.01
-0.08%
Calvert Focused Value I
WFDAX23.47-0.02
-0.09%
Allspring SMID Cap Growth Fund - Cl A

PGNY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PGNY has been loosely correlated with CLSK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if PGNY jumps, then CLSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGNY
1D Price
Change %
PGNY100%
+1.14%
CLSK - PGNY
54%
Loosely correlated
-4.30%
COIN - PGNY
53%
Loosely correlated
-1.18%
RIOT - PGNY
48%
Loosely correlated
-3.45%
HOOD - PGNY
39%
Loosely correlated
-1.92%
MFON - PGNY
38%
Loosely correlated
+3.89%
More

Groups containing PGNY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PGNY
1D Price
Change %
PGNY100%
+1.14%
Managed Health Care
industry (14 stocks)
30%
Poorly correlated
+0.35%